Literature DB >> 24739273

Modulation of the host microenvironment by a common non-oncolytic mouse virus leads to inhibition of plasmacytoma development through NK cell activation.

Gaëtan Thirion1, Anubha Saxena1, Xavier Hulhoven1, Dominique Markine-Goriaynoff1, Jacques Van Snick2, Jean-Paul Coutelier1.   

Abstract

Although many cells undergo transformation, few actually develop into tumours, due to successful mechanisms of immunosurveillance. To investigate whether an infectious agent may play a role in this process, the growth of a plasmacytoma was investigated in mice infected by lactate dehydrogenase-elevating virus. Acutely infected animals were significantly protected against tumour development. The mechanisms responsible for this protection were analysed in mice deficient for relevant immune cells or molecules and after in vivo cell depletion. This protection by viral infection correlated with NK cell activation and with IFN-γ production. It might also be related to activation of NK/T-cells, although this remains to be proven formally. Therefore, our results indicated that infections with benign micro-organisms may protect the host against cancer development, through non-specific stimulation of the host's innate immune system and especially of NK cells.
© 2014 The Authors.

Entities:  

Mesh:

Year:  2014        PMID: 24739273     DOI: 10.1099/vir.0.063990-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development.

Authors:  Mohamed F Mandour; Pyone Pyone Soe; Catherine Uyttenhove; Jacques Van Snick; Etienne Marbaix; Jean-Paul Coutelier
Journal:  Infect Agent Cancer       Date:  2020-05-07       Impact factor: 2.965

2.  Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition.

Authors:  Victoria A Jennings; Gina B Scott; Ailsa M S Rose; Karen J Scott; Gemma Migneco; Brian Keller; Katrina Reilly; Oliver Donnelly; Howard Peach; Donald Dewar; Kevin J Harrington; Hardev Pandha; Adel Samson; Richard G Vile; Alan A Melcher; Fiona Errington-Mais
Journal:  Mol Ther       Date:  2019-04-14       Impact factor: 11.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.